BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price reached a new 52-week high on Tuesday . The company traded as high as $1.54 and last traded at $1.50, with a volume of 11049 shares. The stock had previously closed at $1.51.
BioRestorative Therapies Stock Performance
The company’s 50 day simple moving average is $1.62 and its 200-day simple moving average is $1.60. The firm has a market capitalization of $2.43 billion, a PE ratio of -1.40 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
See Also
- Five stocks we like better than BioRestorative Therapies
- How is Compound Interest Calculated?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Business Services Stocks Investing
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- The 3 Best Retail Stocks to Shop for in August
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
